Lenacapavir, Teropavimab, and Zinlirvimab
Phase II Study Results of Lenacapavir, Teropavimab, and Zinlirvimab for People Living with Virologically Suppressed HIV

Released: March 14, 2025

Expiration: September 13, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: March 14, 2025

Expiration: September 13, 2025